Article
Immunotherapy with cytokine-induced killer cells as an adjuvant treatment for advanced gastric carcinoma: a retrospective study of 165 patients.
Cancer biotherapy & radiopharmaceuticals - 1 May 2013
Zhao Hua, Fan Yongli, Li Hui, Yu Jinpu, Liu Liang, Cao Shui, Ren Baozhu, Yan Fang, Ren Xiubao
Abstract excerpt
BACKGROUND: Cytokine-induced killer (CIK) cells have demonstrated antitumor effects in vitro and in vivo. The purpose of this study was to evaluate the effect of CIK cell treatment as an adjuvant immunotherapy on the prognosis of gastric carcinoma in patients after surgery. METHODS: The patients with stage II-III gastric carcinoma after gastrectomy, including 53 patients receiving autologous CIK cell treatment...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
